Showing results (1-10 of 683) with videos related to
Sort By:
Pageof 69
Nature Clinical Practice. Rheumatology|February 3, 2009
Are statins useful for treating vascular involvement in systemic sclerosis?Jelena Blagojevic, Marco Matucci-CerinicCurrent Rheumatology Reviews|February 19, 2015
Systemic sclerosis: clinical manifestationsJelena Blagojevic, Marco Matucci-CerinicAutoimmunity Reviews|October 23, 2019
Is there today a place for corticosteroids in the treatment of scleroderma?Jelena Blagojevic, Paul Legendre, Marco Matucci-Cerinic, et al.Annals of the New York Academy of Sciences|September 26, 2007
Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosisYaniv Sherer, Marco Matucci Cerinic, Francesca Bartoli, et al.Clinical Rheumatology|July 21, 2016
Premedication prevents infusion reactions and improves retention rate during infliximab treatmentFrancesca Bartoli, Cosimo Bruni, Laura Cometi, et al.Turkish Journal of Medical Sciences|November 30, 2021
Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammationAbdurrahman Tufan, Marco Matucci-CerinicRheumatology (Oxford, England)|June 30, 2009
Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practiceDirk Elewaut, Marco Matucci-CerinicBest Practice & Research. Clinical Rheumatology|November 22, 2011
Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) eraFrancesca Nacci, Marco Matucci-CerinicExpert Opinion on Emerging Drugs|June 10, 2008
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosisGabriele Valentini, Marco Matucci CerinicAutoimmunity Reviews|September 25, 2010
Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosisFelice Galluccio, Marco Matucci-CerinicPageof 69